000 | 01819 a2200517 4500 | ||
---|---|---|---|
005 | 20250513053005.0 | ||
264 | 0 | _c19941216 | |
008 | 199412s 0 0 eng d | ||
022 | _a0021-9258 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBoyan, B D | |
245 | 0 | 0 |
_aLatent transforming growth factor-beta is produced by chondrocytes and activated by extracellular matrix vesicles upon exposure to 1,25-(OH)2D3. _h[electronic resource] |
260 |
_bThe Journal of biological chemistry _cNov 1994 |
||
300 |
_a28374-81 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_a24,25-Dihydroxyvitamin D 3 _xpharmacology |
650 | 0 | 4 |
_aAlkaline Phosphatase _xmetabolism |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCalcitriol _xpharmacology |
650 | 0 | 4 |
_aCartilage, Articular _xdrug effects |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aCell Membrane _xphysiology |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 | _aCulture Media, Conditioned |
650 | 0 | 4 |
_aDNA _xbiosynthesis |
650 | 0 | 4 |
_aExtracellular Matrix _xphysiology |
650 | 0 | 4 |
_aGene Expression _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 | _aLung |
650 | 0 | 4 | _aMink |
650 | 0 | 4 |
_aOrganelles _xphysiology |
650 | 0 | 4 |
_aRNA, Messenger _xanalysis |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aRecombinant Proteins _xpharmacology |
650 | 0 | 4 |
_aThymidine _xmetabolism |
650 | 0 | 4 |
_aTransforming Growth Factor beta _xbiosynthesis |
700 | 1 | _aSchwartz, Z | |
700 | 1 | _aPark-Snyder, S | |
700 | 1 | _aDean, D D | |
700 | 1 | _aYang, F | |
700 | 1 | _aTwardzik, D | |
700 | 1 | _aBonewald, L F | |
773 | 0 |
_tThe Journal of biological chemistry _gvol. 269 _gno. 45 _gp. 28374-81 |
|
999 |
_c7961109 _d7961109 |